Hap Seng Plantations Holdings Berhad

KLSE:HSPLANT Stock Report

Market Cap: RM 1.7b

Hap Seng Plantations Holdings Berhad Valuation

Is HSPLANT undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of HSPLANT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: HSPLANT (MYR2.09) is trading below our estimate of fair value (MYR2.97)

Significantly Below Fair Value: HSPLANT is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for HSPLANT?

Key metric: As HSPLANT is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for HSPLANT. This is calculated by dividing HSPLANT's market cap by their current earnings.
What is HSPLANT's PE Ratio?
PE Ratio11.9x
EarningsRM 140.31m
Market CapRM 1.67b

Price to Earnings Ratio vs Peers

How does HSPLANT's PE Ratio compare to its peers?

The above table shows the PE ratio for HSPLANT vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average11.9x
TSH TSH Resources Berhad
16.9x8.0%RM 1.6b
TAANN Ta Ann Holdings Berhad
11.5x6.5%RM 1.9b
KRETAM Kretam Holdings Berhad
10.4xn/aRM 1.4b
KSENG Keck Seng (Malaysia) Berhad
9.1xn/aRM 2.1b
HSPLANT Hap Seng Plantations Holdings Berhad
11.9x-2.5%RM 1.7b

Price-To-Earnings vs Peers: HSPLANT is good value based on its Price-To-Earnings Ratio (11.9x) compared to the peer average (11.9x).


Price to Earnings Ratio vs Industry

How does HSPLANT's PE Ratio compare vs other companies in the MY Food Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
HSPLANT 11.9xIndustry Avg. 13.6xNo. of Companies9PE0816243240+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: HSPLANT is good value based on its Price-To-Earnings Ratio (11.9x) compared to the MY Food industry average (13.6x).


Price to Earnings Ratio vs Fair Ratio

What is HSPLANT's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

HSPLANT PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio11.9x
Fair PE Ratio12.7x

Price-To-Earnings vs Fair Ratio: HSPLANT is good value based on its Price-To-Earnings Ratio (11.9x) compared to the estimated Fair Price-To-Earnings Ratio (12.7x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst HSPLANT forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentRM 2.09
RM 2.35
+12.2%
6.4%RM 2.70RM 2.20n/a9
Nov ’25RM 1.88
RM 2.13
+13.4%
9.7%RM 2.40RM 1.79n/a9
Oct ’25RM 1.70
RM 2.13
+25.4%
9.7%RM 2.40RM 1.79n/a9
Sep ’25RM 1.70
RM 2.13
+25.4%
9.7%RM 2.40RM 1.79n/a9
Aug ’25RM 1.75
RM 2.09
+19.3%
11.0%RM 2.45RM 1.75n/a9
Jul ’25RM 1.74
RM 2.07
+19.2%
10.5%RM 2.45RM 1.75n/a10
Jun ’25RM 1.78
RM 2.05
+15.4%
9.2%RM 2.40RM 1.75n/a10
May ’25RM 1.85
RM 2.03
+9.9%
8.3%RM 2.30RM 1.75n/a10
Apr ’25RM 1.84
RM 2.03
+10.5%
8.3%RM 2.30RM 1.75n/a10
Mar ’25RM 1.86
RM 2.03
+9.1%
8.1%RM 2.30RM 1.75n/a10
Feb ’25RM 1.83
RM 1.97
+7.7%
10.9%RM 2.30RM 1.70n/a10
Jan ’25RM 1.72
RM 1.97
+14.6%
10.9%RM 2.30RM 1.70n/a10
Dec ’24RM 1.79
RM 2.05
+14.2%
15.0%RM 2.65RM 1.70n/a8
Nov ’24RM 1.80
RM 2.07
+14.8%
13.9%RM 2.65RM 1.70RM 1.887
Oct ’24RM 1.88
RM 2.14
+13.6%
15.2%RM 2.65RM 1.70RM 1.708
Sep ’24RM 1.88
RM 2.14
+13.6%
15.2%RM 2.65RM 1.70RM 1.708
Aug ’24RM 1.98
RM 2.22
+12.3%
13.3%RM 2.65RM 1.79RM 1.757
Jul ’24RM 1.86
RM 2.19
+17.5%
15.1%RM 2.65RM 1.79RM 1.747
Jun ’24RM 1.86
RM 2.21
+19.0%
14.4%RM 2.65RM 1.79RM 1.788
May ’24RM 1.86
RM 2.10
+12.6%
15.8%RM 2.62RM 1.65RM 1.858
Apr ’24RM 1.76
RM 2.10
+19.0%
15.8%RM 2.62RM 1.65RM 1.848
Mar ’24RM 1.89
RM 2.17
+14.8%
13.8%RM 2.62RM 1.65RM 1.868
Feb ’24RM 1.92
RM 2.35
+22.5%
13.9%RM 2.80RM 1.65RM 1.838
Jan ’24RM 1.94
RM 2.35
+21.3%
13.9%RM 2.80RM 1.65RM 1.728
Dec ’23RM 1.98
RM 2.35
+18.8%
13.9%RM 2.80RM 1.65RM 1.798
Nov ’23RM 2.06
RM 2.50
+21.4%
13.4%RM 3.00RM 1.90RM 1.808

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies